Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy

With encouraging antitumor effects, immunotherapy represented by immune checkpoint blockade has developed into a mainstream cancer therapeutic modality. However, only a minority of ovarian cancer (OC) patients could benefit from immunotherapy. The main reason is that most OC harbor a suppressive tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tianyue, Liu, Zhihui, Huang, Liwen, Jing, Jing, Liu, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751906/
https://www.ncbi.nlm.nih.gov/pubmed/36532066
http://dx.doi.org/10.3389/fimmu.2022.1057850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751906/
https://www.ncbi.nlm.nih.gov/pubmed/36532066
http://dx.doi.org/10.3389/fimmu.2022.1057850

Ejemplares similares